May 5th 2012
Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.
May 4th 2012
Anne Katz, from the University of Manitoba, Discusses Cancer and Sexuality
Nurses play vital roles in assuring that patients with metastatic castration-resistant prostate cancer (mCRPC) are optimally treated with sipuleucel-T.
A pilot study has demonstrated a lag in the integration of genetics and genomics into nursing practice, which is an increasingly required professional skill for oncology nurses.
May 2nd 2012
Jayshree Shah, from John Theurer Cancer Center, on the Safety and Efficacy of Nilotinib for Patients With CML
Kim Kelly, from John Theurer Cancer Center, on the Updated MASCC/ISOO Clinical Practice Guidelines for Mucositis
With four full days of programming, dozens of exhibitors, satellite symposia, and thousands of members in attendance, trying to fit everything in at the ONS Annual Congress can prove quite challenging.
April 25th 2012
This year's ONS Annual Congress marks the first at which Mary Gullatte, PhD, RN, APRN, BC, AOCN, will serve as the organization's president.
February 25th 2012
Meeting coverage from the 2012 Oncology Nursing Society Congress held at the New Orleans Ernest N. Morial Convention Center, from May 3-6, 2012.
May 7th 2011
Donna Berry on the Distinguished Researcher Award and Her Advice to Researchers
Carlton Brown Describes Key Messages of the ONS Congress
Keynote Presenter Cancer Survivor Charlie Lustman Lives to Tell His Story
May 6th 2011
Susan Moore Oncology Nurse Practitioner/Consultant, MCG Oncology on Adapting a Practice for Use of Oral Oncolytics
Oral oncolytics are frequently used in cancer treatment and they make up approximately 25% of the medications in the oncology pipeline
Honorary Mistress of Ceremonies Cynthia Nixon kicked off the ONS 36th Annual Congress Cure magazine Extraordinary Healer Award with a rousing tribute
Lymphedema is the treatment-induced buildup of extra lymph fluid in tissues that causes discomforting and potentially debilitating swelling of the limbs
At ONS researchers from the Seattle Cancer Care Alliance (SCCA) discussed their multidisciplinary care coordination approach for treating patients with Provenge
Social media programs allow oncology nurses to network, share information, and learn evidence-based practices
The FDA recently approved the immunotherapy ipilimumab (Yervoy) as a second-line treatment for patients with metastatic melanoma
Elizabeth Blasiak on the Significance of the ONS Congress